Alex Therapeutics

Overview
Activities
News
Preventive Healthcare?
Product stageSegments
Seed
?
Digital Therapeutics (DTx)
?

Alex Therapeutics is a Swedish digital therapeutics (DTx) company that uses its AI-driven platform, Alex DTx, to develop and launch prescription-based digital therapeutics (PDTs) together with pharma and life science companies. These PDTs are built on cognitive behavioral therapy and machine learning, undergo clinical validation and are based on agile systems for ease of gaining regulatory (FDA and CE) approval. Additionally, the firm claims to reduce time-to-market and global deployment.

As of April 2022, Alex had one commercially available DTx, a companion app for smoking cessation. Its pipeline of treatments consists of treatments for nicotine addiction, obesity, anxiety, and depression in patients diagnosed with idiopathic pulmonary fibrosis (IPF), as well as depression and anxiety for patients with breast cancer.

Key customers and partnerships

The company’s most recent partnership was with Pfizer in January 2022, where it built a DTx to treat nicotine addiction. The DTx, which is undergoing clinical trials as of April 2022, will be launched as a reimbursable prescription for Digital Health Applications in Germany. The firm has also partnered with Vicore Pharma to develop its DTx for treating anxiety and depression in patients with IPF.

HQ location:
Birger Jarlsgatan 57 C Stockholm SWE
Founded year:
2018
Employees:
11-50
IPO status:
Private
Total funding:
USD 9.5 mn
Last Funding:
USD 5.1 mn (Series Unknown; Mar 2023)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.